Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Zealand Pharma is a Danish biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative peptide-based medicines. The company explores therapies for rare and chronic diseases, with a particular focus on endocrinology and gastroenterology. Zealand Pharma aims to deliver groundbreaking treatment options for patients worldwide.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Zealand Pharma is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Zealand Pharma last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at 55.34 DKK.
Across its last 3 earnings reports, Zealand Pharma stock moved by ±6% on average the following day. The largest reaction was +9.4% on 05/07/2026; 2 of 3 reactions were positive.
Zealand Pharma has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.